MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Esperanto Technologies™, the leading developer of high-performance, energy-efficient artificial intelligence (AI) inference…
New fund will strengthen Intel’s foundry business and drive adoption of disruptive technologies. SANTA CLARA,…
Company Doubled Team Members and Increased Draw Disbursements by 85% YoY NASHVILLE, Tenn.–(BUSINESS WIRE)–#fintech—Built Technologies,…
Happify Health analysis highlights the potential to reduce healthcare costs among the chronically ill through…
AUSTIN, Texas–(BUSINESS WIRE)–#ai–IoT/AI, an Austin-based startup, recently secured a contract with the U.S. Air Force’s…
SAN MATEO, Calif.–(BUSINESS WIRE)–IntelePeer, a leading communications workflow automation provider, is pleased to announce that…
TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–SentinelOne (NYSE: S), an autonomous cybersecurity platform company, today announced CRN®, a…
CLEVELAND–(BUSINESS WIRE)–#CertificateManagement—Keyfactor, the leader in PKI and machine identity automation, is pleased to announce that…
Company Also Launches its Premier Partner Event, Platform, Kicking Off February 15 INDIANAPOLIS–(BUSINESS WIRE)–#HCI—Scale Computing,…
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the…
Nicosia, Cyprus, Feb. 07, 2022 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) Slavich Noya Technology,…
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company”…
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI),…
BURBANK, CA, Feb. 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated…
Elraglusib will be combined with FOLFIRINOX alone or with Losartan in multi-center Phase 2 clinical…
SUWON, Republic of Korea, Feb. 07, 2022 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950),…
MIAMI, Feb. 07, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
JUPITER, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…